Molecular Oncology, 1574-7891

Journal

More filtering options
  1. 2019
  2. SIPA1L3 methylation modifies the benefit of smoking cessation on lung adenocarcinoma survival: an epigenomic–smoking interaction analysis

    Zhang, R., Lai, L., Dong, X., He, J., You, D., Chen, C., Lin, L., Zhu, Y., Huang, H., Shen, S., Wei, L., Chen, X., Guo, Y., Liu, L., Su, L., Shafer, A., Moran, S., Fleischer, T., Bjaanæs, M. M., Karlsson, A. & 7 othersMaria Planck, Johan Staaf, Helland, Å., Esteller, M., Wei, Y., Chen, F. & Christiani, D. C., 2019, In : Molecular Oncology. 13, 5, p. 1235-1248 14 p.

    Research output: Contribution to journalArticle

  3. 2018
  4. Molecular subtype classification of urothelial carcinoma in Lynch syndrome

    Therkildsen, C., Pontus Eriksson, Mattias Höglund, Mats Jönsson, Gottfrid Sjödahl, Mef Nilbert & Fredrik Liedberg, 2018 Aug 1, In : Molecular Oncology. 12, 8, p. 1286-1295 10 p.

    Research output: Contribution to journalArticle

  5. A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer

    Shen, S., Zhang, R., Guo, Y., Loehrer, E., Wei, Y., Zhu, Y., Yuan, Q., Moran, S., Fleischer, T., Bjaanæs, M. M., Anna Karlsson, Maria Planck, Johan Staaf, Helland, Å., Esteller, M., Su, L., Chen, F. & Christiani, D. C., 2018 Jun, In : Molecular Oncology. 12, 6, p. 913-924

    Research output: Contribution to journalArticle

  6. Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis

    Del Castillo Velasco-Herrera, M., van der Weyden, L., Nsengimana, J., Speak, A. O., Sjöberg, M. K., Bishop, D. T., Göran Jönsson, Newton-Bishop, J. & Adams, D. J., 2018 Feb, In : Molecular Oncology. 12, 2, p. 239-255

    Research output: Contribution to journalArticle

  7. 2017
  8. 2016
  9. Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis

    Anna Sandström Gerdtsson, Christer Wingren, Persson, H., Delfani, P., Nordström, M., Ren, H., Wen, X., Ringdahl, U., Carl A K Borrebaeck & Hao, J., 2016 Oct 1, In : Molecular Oncology. 10, 8, p. 1305-1316 12 p.

    Research output: Contribution to journalArticle

  10. 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer

    Tommaso De Marchi, Liu, N. Q., Stingl, C., Timmermans, M. A., Smid, M., Look, M. P., Tjoa, M., Braakman, R. B. H., Opdam, M., Linn, S. C., Sweep, F. C. G. J., Span, P. N., Kliffen, M., Luider, T. M., Foekens, J. A., Martens, J. W. M. & Umar, A., 2016 Jan, In : Molecular Oncology. 10, 1, p. 24-39 16 p.

    Research output: Contribution to journalArticle

  11. 2015
  12. BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential.

    Severson, T. M., Peeters, J., Majewski, I., Michaut, M., Bosma, A., Schouten, P. C., Chin, S-F., Pereira, B., Goldgraben, M. A., Bismeijer, T., Kluin, R. J. C., Muris, J. J. F., Karin Jirström, Kerkhoven, R. M., Wessels, L., Caldas, C., Bernards, R., Simon, I. M. & Linn, S., 2015, In : Molecular Oncology. 9, 8, p. 1528-1538

    Research output: Contribution to journalArticle

  13. Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.

    Ko, B-K., Lee, S-Y., Lee, Y-H., Hwang, I-S., Persson, H., Rockberg, J., Carl Borrebaeck, Park, D., Kim, K-T., Uhlen, M. & Lee, J-S., 2015, In : Molecular Oncology. 9, 2, p. 398-408

    Research output: Contribution to journalArticle

  14. MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.

    Aakula, A., Leivonen, S-K., Hintsanen, P., Aittokallio, T., Yvonne Ceder, Børresen-Dale, A-L., Perälä, M., Östling, P. & Kallioniemi, O., 2015, In : Molecular Oncology. 9, 7, p. 1287-1300

    Research output: Contribution to journalArticle

  15. Protein expression of BIRC5, TK1, and TOP2A in malignant peripheral nerve sheath tumours - A prognostic test after surgical resection.

    Kolberg, M., Høland, M., Lind, G. E., Ågesen, T. H., Skotheim, R. I., Sundby Hall, K., Nils Mandahl, Smeland, S., Fredrik Mertens, Davidson, B. & Lothe, R. A., 2015, In : Molecular Oncology. 9, 6, p. 1129-1139

    Research output: Contribution to journalArticle

  16. 2014
  17. Interleukin-6 drives melanoma cell motility through p38α-MAPK-dependent up-regulation of WNT5A expression.

    Linnskog, R., Jönsson, G., Lena Axelsson, Prasad, C. & Tommy Andersson, 2014, In : Molecular Oncology. 8, 8, p. 1365-1378

    Research output: Contribution to journalArticle

  18. 2013
  19. WNT-5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells

    Prasad, C. P., Chaurasiya, S. K., Lena Axelsson & Tommy Andersson, 2013 Oct, In : Molecular Oncology. 7, 5, p. 870-83 14 p.

    Research output: Contribution to journalArticle

  20. The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer

    Kashyap, V., Shafqat Ahmad, Nilsson, E. M., Helczynski, L., Kenna, S., Persson, J. L., Gudas, L. J. & Mongan, N. P., 2013, In : Molecular Oncology. 7, 3, p. 555-566

    Research output: Contribution to journalArticle

  21. 2012
  22. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.

    Karolina Holm, Grabau, D., Lövgren, K., Aradottir, S., Sofia Gruvberger, Jillian Howlin, Lao Saal, Ethier, S. P., Pär-Ola Bendahl, Stål, O., Per Malmström, Mårten Fernö, Lisa Rydén, Cecilia Hegardt, Åke Borg & Markus Ringnér, 2012, In : Molecular Oncology. 6, 5, p. 494-506

    Research output: Contribution to journalArticle

  23. 2011
  24. Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo

    Conrotto, P., Andreasson, U., Venera Kuci, Carl Borrebaeck & Sara Ek, 2011, In : Molecular Oncology. 5, p. 527-537

    Research output: Contribution to journalArticle